SCHEMBL124386

SCHEMBL124386

N[C@@H](CCC(=O)OCc1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
MAPK1 P28482 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
SLC15A1 P46059 2/20 0.51
LTA4H P09960 5/20 0.48
IDO1 P14902 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
KMT2A Q03164 2/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
SLC1A3 P43003 1/20 0.46
SLC1A1 P43005 1/20 0.46
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
LMNA P02545 1/20 0.46
CDC25B P30305 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1918223 1.00 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1SLC15A1LTA4H
SCHEMBL124384 1.00 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1SLC15A1LTA4H
Hydrochloric Acid SCHEMBL19839422 0.98 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1SLC15A1LTA4H
Hydrochloric Acid SCHEMBL5274239 0.98 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1SLC15A1LTA4H
Hydrochloric Acid SCHEMBL8006288 0.98 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1SLC15A1LTA4H
Acetic Acid SCHEMBL27602909 0.95 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1SLC15A1LTA4H
SCHEMBL29113794 0.92 ALDH1A1 (0.49) ALDH1A1MAPK1L3MBTL1SLC15A1LTA4H
Glutamic Acid SCHEMBL28192477 0.92 SLC1A1 (0.49) ALDH1A1MAPK1L3MBTL1SLC15A1LTA4H
SCHEMBL28389656 0.92 SLC1A1 (0.49) ALDH1A1MAPK1L3MBTL1SLC15A1LTA4H
SCHEMBL23542536 0.91 ALDH1A1 (0.49) ALDH1A1MAPK1L3MBTL1SLC15A1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1493 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260027218-A1 STAR-SHAPED GRAFT COPOLYMERS POLYPEPTIDE THERAPEUTIC SOLUTIONS S L (ES) 2026-01-29 US claimed
EP-4674441-A1 RARE EARTH NANO FLUORESCENCE-NUCLEAR MEDICINE TUMOR TOMOGRAPHY-THERAPY INTEGRATED PREPARATION, PREPARING METHOD THEREFOR, AND USE METHOD AND USE THEREOF Zhongke Rare Earth Nanotechnology (Hebei) Co., Ltd (CN) 2026-01-07 EP claimed
EP-4532586-A1 STAR-SHAPED GRAFT COPOLYMERS Polypeptide Therapeutic Solutions, S.L. (ES) 2025-04-09 EP claimed
CN-119605880-A Processing technology of floating beam green tea 浮梁县天祥茶号有限公司 2025-03-14 CN claimed
CN-119585343-A Star graft copolymers 多肽治疗解决公司 2025-03-07 CN claimed
CN-115612049-B Compound imitating spider silk structure, preparation method and application thereof 上海凯赛生物技术股份有限公司 2025-02-11 CN claimed
CN-118979320-A Antibacterial and antistatic cellulose blended yarn and preparation method thereof 德州华源生态科技有限公司 2024-11-19 CN claimed
CN-118680883-A Loadable porous structure for use as an implant 瑞艾克斯制药公司 2024-09-24 CN claimed
CN-112933108-B Bone marrow cavity filler doped with polypeptide polymer and application thereof in osteomyelitis treatment 华东理工大学 2024-07-23 CN claimed
CN-115737938-B Polyamino acid composite guided bone regeneration membrane for repairing alveolar bone defect and preparation method thereof 上海大学 2024-07-16 CN claimed
WO-2005059032-A1 COSMETIC APPLICATION OF ROD-COIL POLYMERS L'OREAL (FR) 2005-06-30 WO claimed
WO-2004043995-A2 PROCESS FOR THE PREPARATION OF GLATIRAMER ACETATE BY POLYMERISATION OF N-CARBOXY ANHYDRIDES OF L-ALANINE, L-TYROSINE, BENZYL L-GLUTAMATE AND BENZYLOXYCARBONYL L-LYSINE APOTEX PHARMACHEM INC. (CA) 2004-05-27 WO claimed
EP-1035891-B1 STEREOSPECIFIC DELIVERY OF A DRUG USING ELECTROTRANSPORT ALZA CORP (US) 2003-05-02 EP claimed
US-6136327-A RACEMIC MIXTURE OF DRUG ALZA CORPORATION (US) 2000-10-24 US claimed
EP-1035891-A1 STEREOSPECIFIC DELIVERY OF A DRUG USING ELECTROTRANSPORT ALZA CORPORATION (US) 2000-09-20 EP claimed
WO-1999027990-A2 STEREOSPECIFIC DELIVERY OF A DRUG USING ELECTROTRANSPORT ALZA CORPORATION (US) 1999-06-10 WO claimed
EP-0362031-B1 COMPOUNDS ACTIVE AGAINST MALARIA OF THE TISSUES, AND PROCESS FOR THEIR PREPARATION LA REGION WALLONNE (BE) 1993-07-07 EP claimed
EP-0362031-A1 Compounds active against malaria of the tissues, and process for their preparation LA REGION WALLONNE (BE) 1990-04-04 EP claimed
EP-0213996-B1 RAMIFIED POLYMERS BASED ON LIPOPEPTIDES FORMING THERMOTROPIC AND LYOTROPIC LIQUID CRYSTALS, THEIR USE AND CORRESPONDING MONOMERS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1989-09-06 EP claimed
US-3936469-A Process for preparing N-carboxylic anhydrides of amino acids KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) 1976-02-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260027218-A1 STAR-SHAPED GRAFT COPOLYMERS RHOA, PCNA, HBZ ALDH1A1 4727/4885MAPK1 2042/4885L3MBTL1 1255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.